Search results
Experimental drug may help people quit vaping
UPI· 13 hours agoAn experimental anti-nicotine drug appears to help people quit vaping, a new study says.
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
CNBC· 12 hours agoThe injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24,...
Olive oil could help reduce risk of dying from dementia, Harvard study says
UPI· 1 day ago1 of 2 | Consuming olive oil could help reduce the risk of dying from dementia, regardless of...
OFF! Announce Farewell Shows With Shellac, Fucked Up, and Surfbort
Pitchfork via Yahoo News· 11 hours agoFree LSD tells the story of a sex shop owner (Morris) who falls for a younger woman visiting the...
Drug May Help Folks Kick the Vaping Habit
WFMZ Eastern Pennsylvania and Western New Jersey· 18 hours agoAn experimental anti-nicotine drug appears to help people quit vaping, a new study says. Cytisinicline is a naturally occurring plant-based substance...
Amgen Stock Is Having Its Best Day Since 2009. Why Wall Street Is Excited About Its Weight-Loss...
Barrons.com· 5 days agoFEATURE Amgen stock was on track for its biggest daily gain since 2009 after the company said it saw...
A fifth ‘Misfit’ is accused of murdering Kansas women. Last year, he declared extremist beliefs.
Oklahoma Voice via Yahoo News· 12 hours agoOn the afternoon of July 6 last year, Paul Grice went to the county clerk’s office at the Cimarron...
Psychedelic Pioneer Peggy Mellon Hitchcock Dies at 90
High Times· 2 days agoMargaret “Peggy” Mellon Hitchcock, an ultra-wealthy heiress who grew up in the Andrew Mellon estate and its fortunes, funded LSD-fueled adventures for Dr. Timothy Leary and Dr. Richard “Ram ...
Do dying people have a 'right to try' magic mushrooms? 9th Circuit weighs case
LA Times via AOL· 7 days agoIn a case that could shape the future of psychedelic medicine, a palliative care physician is...
Gossamer sells rights to drug it hopes can rival a new Merck therapy
BioPharma Dive via Yahoo Finance· 2 days agoOne analyst thinks the collaboration “bodes well” for Gossamer, which has had trouble convincing...
